These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16221785)

  • 21. [Acellular pertussis vaccine--effective but expensive].
    Mertsola J
    Duodecim; 2002; 118(1):75-6. PubMed ID: 12229002
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiology of pertussis and use of acellular pertussis vaccines in Japan.
    Kuno-Sakai H; Kimura M
    Dev Biol Stand; 1997; 89():331-2. PubMed ID: 9272368
    [No Abstract]   [Full Text] [Related]  

  • 23. Japanese experience with 60 million doses of acellular pertussis vaccines.
    Sato H
    Dev Biol Stand; 1997; 89():327-9. PubMed ID: 9272367
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection.
    Heininger U; Stehr K; Christenson P; Cherry JD
    Clin Infect Dis; 1999 Mar; 28(3):602-4. PubMed ID: 10194085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.
    Vesikari T; Van Damme P; Lindblad N; Pfletschinger U; Radley D; Ryan D; Vuocolo S; Haupt RM; Guris D
    Pediatr Infect Dis J; 2010 Apr; 29(4):314-8. PubMed ID: 19952980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
    Olin P
    Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whooping cough in Finland 1920-1978. Statistical and epidemiological studies.
    Huovila R
    Acta Paediatr Scand Suppl; 1982; 298():1-29. PubMed ID: 6305107
    [No Abstract]   [Full Text] [Related]  

  • 28. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
    Wilson TR
    J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Dylag AM; Shah SI
    Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunity to pertussis.
    Cherry JD
    Clin Infect Dis; 2007 May; 44(10):1278-9. PubMed ID: 17443463
    [No Abstract]   [Full Text] [Related]  

  • 31. Absolute efficacy of acellular pertussis vaccines in household settings.
    Storsaeter J; Gustafsson L
    Dev Biol Stand; 1997; 89():153-9. PubMed ID: 9272345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acellular pertussis vaccines pertinent issues.
    Mathew JL
    Indian Pediatr; 2008 Sep; 45(9):727-9. PubMed ID: 18820375
    [No Abstract]   [Full Text] [Related]  

  • 33. Preventing pertussis in infants by vaccinating adults.
    Finger R; Shoemaker J
    Am Fam Physician; 2006 Aug; 74(3):382. PubMed ID: 16913156
    [No Abstract]   [Full Text] [Related]  

  • 34. From the Centers for Disease Control and Prevention. Pertussis--United States, 1997-2000.
    JAMA; 2002 Feb; 287(8):977-9. PubMed ID: 11871441
    [No Abstract]   [Full Text] [Related]  

  • 35. Tetanus, diphtheria, and acellular pertussis vaccine: a position statement of the Society for Adolescent Medicine.
    Middleman AB; Bruner A
    J Adolesc Health; 2009 Sep; 45(3):316-7. PubMed ID: 19699431
    [No Abstract]   [Full Text] [Related]  

  • 36. Experiences with a new combined vaccine against B. parapertussis, diphtheria, tetanus and B. pertussis employed in a field trial in Prague 10.
    Buriănová-Vysoká B; Burian V; Kriz B; Pellar T; Hellerová J; Radkovský J
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(4):481-7. PubMed ID: 4321988
    [No Abstract]   [Full Text] [Related]  

  • 37. Persistent pertussis.
    Ortolon K
    Tex Med; 2002 Jun; 98(6):38-42. PubMed ID: 12073900
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of pertussis and high expectations concerning vaccines].
    Wysocki J
    Przegl Epidemiol; 2004; 58 Suppl 1():39-43. PubMed ID: 15807156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of prophylactic whooping-cough vaccination. An attempt at an evaluation based on experiences in Denmark].
    Lautrop H; Mikkelsen OS
    Ugeskr Laeger; 1969 Apr; 131(17):735-41. PubMed ID: 4307508
    [No Abstract]   [Full Text] [Related]  

  • 40. Japanese clinical trials with Takeda acellular pertussis vaccine.
    Kuno-Sakai H; Kimura M; Ozaki K; Isomura S; Kamiya H; Nii R; Kato T; Horiuchi K; Syukuda Y; Fujita I
    Tokai J Exp Clin Med; 1988; 13 Suppl():15-9. PubMed ID: 2908519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.